Business Context and Reporting Period
Company: PMGC Holdings Inc. (Nasdaq: ELAB)
Filing Type: Form 8-K (Current Report)
Date of Report: April 16, 2026
Event: Entry into a Material Definitive Agreement (Securities Purchase Agreement) establishing an equity line of credit.
Key Financial Metrics and Transaction Details
- Total Commitment Amount: Up to $40,000,000 in Pre-Paid Purchases.
- Initial Pre-Paid Purchase Principal: $10,730,000.
- Initial Cash Proceeds: $10,000,000 (calculated as principal less $700,000 OID and $30,000 transaction expenses).
- Additional Registered Shares: 262,467 shares purchased by Investor for $1,000,000.
- Expected Net Proceeds: Approximately $9,727,380 after placement agent fees and other transaction costs.
- Subsequent Purchase Terms: 7% Original Issue Discount (OID) and 7% annual interest accrual.
- Share Reserve: 7,500,000 shares reserved for issuances under the agreement.
Material Changes and Structural Agreements
The filing details a significant capital raise structure rather than operational performance changes. Key structural elements include:
- Commitment Period: April 16, 2026, to April 16, 2028, or until the $40 million cap is reached.
- Guaranty and Collateral: Five wholly-owned subsidiaries (Northstrive Biosciences, PMGC Capital, AGA Precision Systems, Pacific Sun Packaging, and SVM Machining) entered into Guaranties. The Company pledged equity interests in these subsidiaries and future acquisitions as collateral, granting the Investor a first-position security interest.
- Participation Right: The Investor holds the right to participate in up to 10% of future debt or equity financings on the most favorable terms.
- Sales Cap: The Investor is restricted from selling more than 15% of the weekly trading volume of Common Stock in any calendar week.
Outlook, Risks, and Management Commentary
- Regulatory Requirements: The Company must obtain stockholder approval for issuances exceeding the 19.99% Nasdaq issuance cap and file a Schedule 14C Information Statement.
- Registration: The Company agreed to file a Form 424(b)(5) prospectus supplement on Form S-3 to register the shares.
- Restrictions: The Company is restricted from entering into other Variable Rate Transactions or issuing securities to the Investor or its affiliates without prior written consent.
- Termination: The Company may terminate the agreement with 10 days' notice if no Pre-Paid Purchases are outstanding.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received (expected ~$9.73 million).
- Confirm the status of the stockholder approval vote required for issuances exceeding the 19.99% Nasdaq cap.
- Review the impact of the 7% OID and 7% interest accrual on future dilution and interest expense.
- Assess the implications of the first-position security interest on the Company's subsidiaries for future financing flexibility.
- Monitor the Investor's exercise of the 10% participation right in future capital raises.